FDA
-
-
-
-
-
-
-
Medtronic to Acquire Intersect ENT
-
-
-
-
-
-
-
CMS Consolidates SINUVA Sinus Implant Coverage Under a Distinct Code, J7402, and Publishes an ASP Clarifying Payment and Easing Payer Coverage Adjudication
-
-
-
-
-
-
-
Alydia Announces $13.9 Million Financing for Innovative Postpartum Hemorrhage Treatment, Appoints Robert Binney as CEO and Colby Holtshouse as COO
-
-
-
-
-
-
-
Intersect ENT (XENT) ASCEND Study of Investigational Drug-Coated Balloon for Sinus Dilation Did Not Meet its Primary Endpoint
-
-
-
-
-
-
-
Pre-Open Movers 05/07: (SEDG) (EVER) (DF) Higher; (CPRX) (XENT) (NLS) (more...)
-
-
-
-
-
-
-
Intersect ENT Reports Second Quarter 2018 Results
-
-
-
-
-
-
-
Intersect ENT Announces Publication of Randomized Pivotal Study of the SINUVA™ Sinus Implant, a New In-Office Treatment Option for Recurrent Nasal Polyps
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

